A new joint working project between Novartis and the Royal Marsden Partners Cancer Vanguard is being piloted in North West and South West London. The project aims to improve quality of care in the region by expanding the role of oncology pharmacists to address increasing demand on oncology services.

The project will develop and introduce new models of care to improve the delivery of treatment, as well as quality and consistency of care for patients. The project will focus on the care of patients with solid tumours, including advanced melanoma, breast, lung, and renal cell carcinoma.

It is hoped that the partnership will bring “quantifiable improvements for patients including ensuring quick access to appropriate treatments, accurate drug prescription verification, and address issues with the delivery of treatments, for instance using a mobile chemotherapy bus service to increase convenience to patients,” they said.

Read more in PharmaTimes online here